shu-508 and Colorectal-Neoplasms

shu-508 has been researched along with Colorectal-Neoplasms* in 5 studies

Trials

2 trial(s) available for shu-508 and Colorectal-Neoplasms

ArticleYear
Improved detection of liver metastases with phase inversion ultrasound during the late phase of levovist.
    Academic radiology, 2002, Volume: 9 Suppl 1

    Topics: Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Humans; Liver Neoplasms; Lung Neoplasms; Polysaccharides; Ultrasonography

2002
Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: a preliminary report.
    The British journal of surgery, 1994, Volume: 81, Issue:2

    The clinical application of ultrasonographic contrast agents in colour Doppler flow imaging of hepatic tumours is receiving increasing attention. Levovist is a suspension of galactose microparticles that provides reproducible concentrations of stabilized air bubbles with transpulmonary stability. Its effect on colour Doppler imaging was assessed in 26 patients with colorectal cancer and histologically proven hepatic metastases. Colour Doppler flow imaging was performed before and after intravenous injection of 10 ml Levovist 300 mg/ml. At 5-10 s after injection there was significant enhancement of the hepatic lesions with colour Doppler signals in 23 patients, lasting for a mean(s.d.) of 180(45) s. A consistent pattern of colour Doppler signal was observed, with increased enhancement predominantly around the tumour periphery and little or no central enhancement. These data suggest that Levovist may increase the sensitivity and specificity of colour Doppler flow imaging of colorectal hepatic metastases.

    Topics: Adult; Aged; Color; Colorectal Neoplasms; Contrast Media; Humans; Liver; Liver Neoplasms; Middle Aged; Polysaccharides; Ultrasonography

1994

Other Studies

3 other study(ies) available for shu-508 and Colorectal-Neoplasms

ArticleYear
[Quantification of hepatic arterial and portal venous flow using ultrasound contrast agents for early detection of liver metastases of colorectal cancers].
    Journal de radiologie, 2001, Volume: 82, Issue:11

    To quantify liver blood flow using US contrast agents and to evaluate arterial and portal changes in control patients and patients with liver metastases.. Twenty eight patients were included in this study, 8 controls (M0) and 20 patients with liver metastases from colon carcinoma (M+). Hepatic blood flow from hepatic artery and portal vein were determined using quantification of enhancement after contrast injection using Power Doppler US. The ratio of enhancement rise from artery and vein allows calculation of Contrast Enhanced Doppler Perfusion Index (CEDPI) as previously described for Doppler Perfusion Index (DPI).. A significant difference was noted for CEDPI between controls (0.49 +/- 0.07) and liver with metastases (0.70 +/- 0.12).. This functional method of evaluation of liver blood flow was easy to perform, and would be valuable for early detection of overt micro-metastases before anatomical changes observed by conventional imaging. This is helpful for accurate staging of colon carcinoma.

    Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Data Interpretation, Statistical; Female; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Polysaccharides; Portal Vein; Ultrasonography, Doppler

2001
Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases.
    Lancet (London, England), 2000, Mar-04, Volume: 355, Issue:9206

    Pulse-inversion mode (a new ultrasound mode) can be used to image the late liver-specific parenchymal phase of the microbubble contrast-agent Levovist. Scanning in pulse-inversion mode after Levovist improves the detection of liver metastases and reveals more lesions of smaller size than conventional ultrasonography and computed tomography.

    Topics: Colorectal Neoplasms; Contrast Media; Humans; Image Enhancement; Liver Neoplasms; Polysaccharides; Sensitivity and Specificity; Ultrasonography

2000
Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience.
    Radiology, 1999, Volume: 211, Issue:3

    To evaluate contrast agent-enhanced ultrasonography (US) in the detection of untreated tumor after radio-frequency (RF) ablation of hepatic metastases.. Twenty patients with solitary colorectal liver metastases underwent percutaneous RF tumor ablation. Pre- and postablation imaging was performed with nonenhanced and enhanced color and power Doppler US and contrast-enhanced helical computed tomography (CT). Initial follow-up CT and US were performed 24 hours after ablation. The findings at US and CT were compared.. Nonenhanced US demonstrated intratumoral signal in 15 of 20 metastases before ablation. This signal increased after contrast agent administration. Contrast-enhanced US performed 24 hours after ablation demonstrated residual foci of enhancement in three tumors, whereas no US signals were seen in any tumor on nonenhanced scans. CT demonstrated small (< 3-mm) persistent foci of residual enhancement in these three tumors and in three additional lesions that were not seen at US (US sensitivity, 50%; specificity, 100%; diagnostic agreement with CT, 85%). All six patients with evidence of residual tumor underwent repeat RF ablation.. Contrast-enhanced US may depict residual tumor after RF application and thereby enable additional directed therapy. The potential reduction in treatment sessions and/or ancillary imaging procedures might increase the ease and practicality of percutaneous ablation of focal hepatic metastases.

    Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Humans; Liver Neoplasms; Middle Aged; Neoplasm, Residual; Polysaccharides; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Ultrasonography, Interventional

1999